K2 HealthVentures (K2HV) is an alternative investment firm that provides flexible, long-term financing solutions to innovative private and public companies in the life sciences and healthcare industries. We are healthcare specialists with deep domain expertise, and we understand both the opportunities and challenges that face venture-stage and growth-stage companies. Further, our flat organizational set-up enables nimble decision-making, and our evergreen fund structure allows us to be creative and adapt our facilities to a company’s specific needs over both the short and the long term. Over the last 4 years we have committed more than $1 billion in debt and equity capital to both private and public companies, and our team’s track record spans decades of investing in and supporting innovative life sciences and healthcare companies (with over $4 billion total investments in over 100 portfolio companies).
32
Total Investments
30
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About K2 HealthVentures
Recent Investments (32)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series C | •••••• | Jan 2025 | |
| Debt Financing | •••••• | Nov 2023 | |
| Post-IPO Equity | •••••• | Oct 2023 | |
| Post-IPO Debt | •••••• | Aug 2023 | |
| Private Placement Vc | •••••• | Feb 2023 | |
|
|
Debt Financing | •••••• | Jan 2023 |
|
|
Post-IPO Debt | •••••• | Jan 2023 |
|
|
Private Equity Round | •••••• | Jan 2023 |
|
|
Private Equity Round | •••••• | Jan 2023 |
|
|
Debt Financing | •••••• | Jan 2023 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.